Ejal 40 BioRevitalizer is a professional skin booster formulated with high-concentration hyaluronic acid to support skin hydration, elasticity, and overall dermal quality. Designed for use by qualified healthcare professionals, the treatment is commonly incorporated into aesthetic medicine protocols aimed at improving the appearance of ageing or dehydrated skin.
The product is widely recognised for its role in bio-revitalisation programmes and is often selected for patients seeking improvements in skin texture, firmness, and hydration without volumising effects. Whether researching ejal 40 skin booster, comparing ejal 40 price, or looking to buy ejal 40, practitioners frequently consider Ejal 40 as part of comprehensive skin-quality treatment strategies.
Pricing is available to registered aesthetic professionals only.
Sign in to view pricesEjal 40 is a bio-revitalising injectable medical device developed by Medixa Srl for improving skin quality, hydration, and dermal support in patients showing signs of intrinsic and extrinsic skin ageing. Classified as a skin booster and biorevitalisation treatment, Ejal 40 contains high-molecular-weight hyaluronic acid at a concentration of 40 mg per 2 ml syringe, formulated to support extracellular matrix integrity and promote a more hydrated, elastic, and refreshed appearance.
Unlike volumising dermal fillers, Ejal 40 is designed primarily to improve skin quality rather than create structural volume. The product is frequently used in protocols intended to address skin laxity, dehydration, and early age-related dermal changes affecting the face, neck, décolletage, and hands.
Through the hydrophilic properties of hyaluronic acid, Ejal 40 supports water retention within the dermis and contributes to improved tissue hydration and skin texture.
Ejal 40 belongs to the same category of injectable skin boosters and biorevitalisation products as Profhilo®, Sunekos®, and other hyaluronic acid-based regenerative aesthetic treatments.
Compared with Profhilo®, which combines high- and low-molecular-weight hyaluronic acid using a thermal stabilisation process, Ejal 40 uses high-molecular-weight hyaluronic acid designed to support skin hydration and dermal quality through bio-revitalisation protocols.
Compared with Sunekos®, which combines hyaluronic acid with amino acids to support extracellular matrix activity, Ejal 40 focuses primarily on high-concentration hyaluronic acid as its principal active ingredient.
All of these products are intended to improve skin quality rather than provide significant volumisation. Treatment schedules, clinical outcomes, and longevity may differ depending on patient characteristics and practitioner protocols.
This comparison is provided for clinical orientation only and does not imply interchangeability.
According to manufacturer documentation, Ejal 40 may be used in areas showing signs of skin ageing and reduced dermal quality, including:
Clinical objectives include:
Injection depth: Intradermal injection.
Frequency / number of sessions: Publicly available manufacturer documentation describes treatment cycles; however, exact frequency parameters are not consistently specified in accessible IFU documentation. Therefore: not provided by manufacturer.
Professional-use disclaimer: Ejal 40 should be administered exclusively by qualified medical professionals trained in aesthetic injection procedures and under appropriate aseptic conditions.
Some practitioners utilise the well-known 4-point BioRevitalization Technique (4PBT®) with Ejal 40; however, specific practitioner protocols may vary and should not be considered a substitute for the manufacturer’s official IFU.
Lidocaine: No.
Longevity is not explicitly guaranteed by the manufacturer and may vary according to patient characteristics, treatment area, lifestyle factors, and practitioner protocol. Publicly available clinical and distributor information suggests treatment programmes commonly involve multiple sessions, but exact duration is not provided by manufacturer.
According to manufacturer guidance and standard injectable medical-device precautions, Ejal 40 should not be used in:
Additional precautions include:
UKCA status: Verify via current IFU, importer documentation, or authorised UK distributor.
Ejal 40 is a hyaluronic acid-based bio-revitalisation treatment designed to improve skin hydration, elasticity, and overall dermal quality. It is commonly used in aesthetic medicine for patients presenting with skin ageing, dehydration, and reduced firmness.
Ejal 40 differs from traditional dermal fillers because its primary objective is skin revitalisation rather than volumisation. While it contains hyaluronic acid, the treatment focuses on improving skin quality and hydration rather than restoring facial volume or contour.
Manufacturer information identifies the face, neck, décolletage, and hands as principal treatment areas. These regions commonly exhibit age-related changes such as dehydration, reduced elasticity, and diminished skin quality.
No. Public manufacturer specifications indicate that Ejal 40 contains high-molecular-weight hyaluronic acid in a physiological buffer but does not contain lidocaine.
Ejal 40 belongs to the same broad category as Profhilo® and Sunekos®. While all aim to improve skin quality, they differ in formulation technology and ingredient composition. Ejal 40 relies primarily on high-concentration hyaluronic acid for bio-revitalisation and hydration support.
Let’s talk on WhatsApp